journal article·2026-03

Lesion-targeted, severity-responsive nanoparticle delivery for RNA therapy in osteoarthritis

Claudio Intini, Fergal J. O’Brien

Nature Nanotechnology· Volume 21· Issue 3
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · RNA Interference and Gene Delivery · Advancements in Transdermal Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (11)

Show source-provided references
1. Leifer, V. P., Katz, J. N. & Losina, E. Osteoarthr. Cartil. 30, 10–16 (2022).10.1016/j.joca.2021.05.007 ↗
2. Hodgkinson, T., Kelly, D. C., Curtin, C. M. & O’Brien, F. J. Nat. Rev. Rheumatol. 18, 67–84 (2022).10.1038/s41584-021-00724-w ↗
3. Schambach, A. et al. Lancet 403, 568–582 (2024).10.1016/S0140-6736(23)01952-9 ↗
4. Dewani, M. Nat Nanotechnol. https://doi.org/10.1038/s41565-025-02101-0 (2025).10.1038/s41565-025-02101-0 ↗
5. Thi, T. T. H. et al. Vaccines 9, 359 (2021).10.3390/vaccines9040359 ↗
6. Alsaab, H. O. et al. Pharmaceutics 14, 2728 (2022).10.3390/pharmaceutics14122728 ↗
7. Geng, G. et al. EBioMedicine 118, 105834 (2025).10.1016/j.ebiom.2025.105834 ↗
8. Joyce, M. et al. Eur. Cell. Mater. 47, 91–108 (2024).10.22203/eCM.v047a07 ↗
9. Zhong, R. et al. Nat. Mater. 22, 818–831 (2023).10.1038/s41563-023-01472-w ↗
10. Intini, C. et al. Adv. Therap. 6, 2200329 (2023).10.1002/adtp.202200329 ↗
11. An, S. et al. Mater. Today Bio. 30, 101382 (2025).10.1016/j.mtbio.2024.101382 ↗